Scarica l'app Stockscreener
11.53
0.79%
0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Biohaven Ltd Borsa (BHVN) Ultime notizie
Biohaven (BHVN): Evaluating Valuation After New BHV-1510 Oncology Data at ESMO Immuno-Oncology Congress - simplywall.st
Bellevue Group AG Raises Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat
Certain options of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2025. - marketscreener.com
Certain warrants of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2025. - marketscreener.com
Biohaven Ltd. $BHVN Position Trimmed by Redmile Group LLC - MarketBeat
Armistice Capital LLC Raises Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat
Biohaven jumps on early-stage data for antibody drug conjugate combo - Seeking Alpha
Why Biohaven (BHVN) Is Up 16.2% After New Trop2 ADC Combo Data At ESMO IO 2025 – And What's Next - simplywall.st
Biohaven stock jumps after promising cancer drug results By Investing.com - Investing.com Nigeria
Biohaven stock jumps after promising cancer drug results - Investing.com India
Biohaven presents data for BHV-1510 at ESMO - TipRanks
Biohaven reports promising results for cancer drug BHV-1510 - Investing.com
Biohaven reports promising results for cancer drug BHV-1510 By Investing.com - Investing.com South Africa
Biohaven shares cancer drug trial results at European oncology meeting - StreetInsider
Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress - PR Newswire
Biohaven (NYSE:BHVN) Stock Price Down 5%What's Next? - MarketBeat
Norges Bank Makes New $12.74 Million Investment in Biohaven Ltd. $BHVN - MarketBeat
Biohaven (NYSE:BHVN) Trading Up 8.8%Still a Buy? - MarketBeat
FY2025 EPS Estimates for Biohaven Increased by HC Wainwright - MarketBeat
Responsive Playbooks and the BHVN Inflection - news.stocktradersdaily.com
Biohaven Ltd. $BHVN Position Lowered by Panagora Asset Management Inc. - MarketBeat
Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - MSN
How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 127.52% - Eastern Progress
Why Biohaven Ltd. stock could rally in 2025Jobs Report & Weekly Consistent Profit Watchlists - Newser
HC Wainwright Comments on Biohaven FY2029 Earnings - MarketBeat
Will Biohaven Ltd. Common Shares stock beat international competition2025 Institutional Moves & Weekly Setup with High ROI Potential - Newser
Will Biohaven Ltd. stock beat EPS estimatesJuly 2025 Sector Moves & Real-Time Chart Pattern Alerts - Newser
Does Biohaven Ltd. stock trade at a discount to peersWeekly Trend Summary & Stock Portfolio Risk Management - Newser
Is Biohaven Ltd. Common Shares stock dividend growth reliableJuly 2025 Earnings & Low Risk Entry Point Guides - Newser
Biohaven (NYSE:BHVN) Shares Gap DownTime to Sell? - MarketBeat
Why Biohaven Ltd. Common Shares stock signals breakout potentialMarket Growth Summary & Long-Term Safe Investment Ideas - Newser
This Wayfair Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
HC Wainwright Downgrades Biohaven to Neutral From Buy, Adjusts Price Target to $11 From $30 - marketscreener.com
Biohaven (BHVN) Receives Downgrade and Price Target Cut by HC Wa - GuruFocus
Biohaven downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
JPMorgan Chase & Co. Grows Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat
Capital Fund Management S.A. Grows Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat
Is Biohaven Ltd. Common Shares stock a defensive play amid uncertaintyPortfolio Value Summary & High Accuracy Trade Signal Alerts - Newser
Why Biohaven Ltd. stock appeals to dividend seekersJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Why Is Biohaven Ltd. (BHVN) Stock Down Today? - Meyka
Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
What downside risks could hit Biohaven Ltd. Common Shares stockWeekly Trade Recap & Pattern Based Trade Signal System - Newser
Biohaven (BHVN): Evaluating Valuation After UBS Downgrade and Shifting Analyst Sentiment - simplywall.st
Biohaven Ltd. $BHVN Stake Boosted by Geode Capital Management LLC - MarketBeat
Biohaven (BHVN): Assessing Valuation After Recent Share Price Boost - Yahoo Finance
Why Biohaven Ltd. Common Shares stock is a strong analyst pickCEO Change & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
The Bull Case For Biohaven (BHVN) Could Change Following Recent Analyst Downgrades - simplywall.st
RSI Check: Why retail investors favor Biohaven Ltd. stockM&A Rumor & Consistent Profit Trading Strategies - moha.gov.vn
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? - AOL.com
Can Biohaven Ltd. stock outperform in 2025 bull market2025 Market WrapUp & Long Hold Capital Preservation Plans - moha.gov.vn
UBS Downgrades Biohaven (BHVN) - MSN
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):